Loading....
We look forward to seeing you virtually on August 5 from 10:30am-5pm (eastern) for the Drug Repurposing: Considerations for Selection Criteria and Prioritization hybrid public meeting. A confirmation email will be sent. We have also received your request to provide public comment. Our goal is to ensure a variety of perspectives are shared; therefore, we will allocate speaking slots across stakeholder groups. Notifications will be made by the close of business on Friday, July 24. Webinar details are below.
Webinar Information (add this information to your calendar)
Please click the link below to join the webinar:
https://us06web.zoom.us/j/82028040286
Or One tap mobile :
+13017158592,,82028040286# US (Washington DC)
+16469313860,,82028040286# US
Or Telephone:
Dial (for higher quality, dial a number based on your current location):
+1 301 715 8592 US (Washington DC)
+1 312 626 6799 US (Chicago)
+1 646 558 8656 US (New York)
+1 346 248 7799 US (Houston)
+1 720 707 2699 US (Denver)
+1 253 215 8782 US (Tacoma)
Webinar ID: 820 2804 0286
International numbers available: https://us06web.zoom.us/u/kbKuJL2egK